Evidence map›Paper›PMID 38532961›Full record

ArticleOpen forum infectious diseases2024

Quantifying the Cost of

Chloe Morozoff, Naveed Ahmed, Jobiba Chinkhumba, Md Taufiqul Islam, Abdoulie F Jallow, Billy Ogwel, Loyda Fiorella Zegarra Paredes, Doh Sanogo, Hannah E Atlas, Henry Badji and 33 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 13 institutions in 9 countries.

Chloe MorozoffDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Naveed AhmedDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Jobiba ChinkhumbaSchool of Global and Public Health, Department of Health Systems and Policy, Kamuzu University of Health Sciences, Blantyre, Malawi.
Md Taufiqul IslamInfectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
Abdoulie F JallowMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Billy OgwelKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Loyda Fiorella Zegarra ParedesAsociación Benéfica PRISMA, Iquitos, Peru.
Doh SanogoCentre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
Hannah E AtlasDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Henry BadjiMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Naor Bar-ZeevInternational Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Bakary ContehMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Mario Güimack FajardoAsociación Benéfica PRISMA, Iquitos, Peru.
Erika FeutzDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Fadima C HaidaraCentre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
Mehrab KarimMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Adama Mamby KeitaCentre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
Youssouf KeitaCentre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
Farhana KhanamInfectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
Margaret N KosekDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Rebecca MaguireCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ishmail S MbutukaMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
Maureen NdalamaMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
John Benjamin OchiengKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Collins OkelloCentre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
Richard OmoreKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Karin F Perez GarciaAsociación Benéfica PRISMA, Iquitos, Peru.
Farah Naz QamarDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Syed Qudrat-E-KhudaInfectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
Sonia QureshiDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Md Nazmul Hasan RajibInfectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
Wagner Valentino Shapiama LopezAsociación Benéfica PRISMA, Iquitos, Peru.
Shazia SultanaDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Desiree WitteMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
Mohammad Tahir YousafzaiDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Alex O AwuorKenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Nigel A CunliffeInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
M Jahangir HossainMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Maribel Paredes OlorteguiAsociación Benéfica PRISMA, Iquitos, Peru.
Milagritos D TapiaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
K ZamanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.
Arianna Rubin MeansDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Aga Khan University · PKCentre Pour le Développement des Vaccins-Mali · MLInternational Centre for Diarrhoeal Disease Research · BDMRC Unit the Gambia · GMPrisma · PEKenya Medical Research Institute · KEUniversity of Washington · USUniversity of Maryland, Baltimore · USMalawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity of Liverpool · GBJohns Hopkins University · USKamuzu Central Hospital · MWUniversity of Virginia · US

Funding

Enabling Infectious Disease Research Capacity in the Peruvian AmazonD43TW010913 · FIC · UNIVERSITY OF VIRGINIA · PI Margaret N Kosek, MARIBEL PAREDES OLORTEGUI · 2018 to 2026
$2.8M
FIC NIH HHS D43 TW010913
6 · The paper itself

Abstract

Background: Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH) Methods: EFGH working groups comprising representatives from each country (Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia) developed the study methods. Over a 24-month surveillance period, facility-based surveys will collect data on resource use for the medical treatment of an estimated 9800 children aged 6-35 months with diarrhea. Through these surveys, we will describe and quantify medical resources used in the treatment of diarrhea (eg, medication, supplies, and provider salaries), nonmedical resources (eg, travel costs to the facility), and the amount of caregiver time lost from work to care for their sick child. To assign costs to each identified resource, we will use a combination of caregiver interviews, national medical price lists, and databases from the World Health Organization and the International Labor Organization. Our primary outcome will be the estimated cost per inpatient and outpatient episode of medically attended Conclusions: Results from this study will contribute to the existing body of literature on diarrhea costing and inform future policy decisions related to investments in preventive strategies for

Indexed as

costcost of illnessdiarrheahealth economicsShigella

Identifiers

PMID38532961
PMCPMC10962725
OpenAlexW4393166998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.